Blog - Page 3250 of 5437

TuesdayApr 19, 2011 12:34 pm

Kodiak Oil and Gas Corp. (KOG) Updates Oil and Gas Operations in North Dakota

Kodiak Oil and Gas Corp. disclosed updated information on its oil and gas activities in North Dakota where the company is exploring and developing various hydrocarbon bearing formations. Kodiak Oil and Gas is currently utilizing two drilling rigs in its program and will take delivery of a third rig before the end of April 2011. The company is also engaged in negotiations to obtain a fourth rig and plans to take delivery of this rig in the fourth quarter of 2011. Kodiak Oil and Gas has a total of 61,000 net acres under lease in Dunn and McKenzie Counties in…

TuesdayApr 19, 2011 12:33 pm

Medical Care Technologies, Inc. (MDCE) to Establish Joint Venture in China

Medical Care Technologies, Inc. is an information technology provider to the healthcare industry in China. The company's products and services are geared to China's growing upper and middle classes and include health clinics for children and a healthcare delivery and wellness site. The company today announced that it has signed a Letter of Intent (LOI) with Ocean Wise International Industrial Limited, a private Hong Kong investment holding company. The intent of the LOI is to establish a joint venture for the purpose of opening and operating private, high-quality pediatric clinics throughout China. The non-binding letter of intent only outlines a…

TuesdayApr 19, 2011 9:28 am

Aoxing Pharmaceutical (AXN) Joint Venture Adopts Macfarlan Smith’s Advanced Technology

Aoxing Pharmaceutical, a specialty pharmaceutical company engaged in researching, developing, manufacturing and distributing narcotic and pain-management products, today announced that Hebei Aoxing API Pharmaceutical Company, Ltd., the joint venture between Aoxing Pharma and Macfarlan Smith Ltd., has successfully adopted advanced process technology from Macfarlan Smith. This technology transfer will allow the joint venture to produce naloxone hydrochloride API (active pharmaceutical ingredient) at both European and Chinese pharmacopoeia specifications. Last week, John Fowler, President at Johnson Matthey Pharmaceutical Materials & Services, and Roger Kiburn, Managing Director at Johnson Matthey Pharmaceuticals, visited the facility located in Xinle City, Hebei Province. "We are…

TuesdayApr 19, 2011 9:20 am

Spartan Motors, Inc. (SPAR) Subsidiary Receives $3 Million Subcontract

Spartan Chassis, Inc., a subsidiary of Spartan Motors, Inc., today announced it has received a subcontract order worth over $3 million to integrate and deliver key chassis components for RG-33 Special Operations Command (SOCOM) Mine Resistant Ambush Protected (MRAP) vehicles. It is anticipated that the vehicles will be delivered in the second and third quarters of 2011. "The threat of improvised explosive devices, or IEDs, remains a very clear and present danger in different regions of the world," stated John Sztykiel, President and CEO of Spartan Motors. "Spartan continues to leverage its expertise and agility alongside original equipment manufacturers such…

TuesdayApr 19, 2011 8:56 am

Cumberland Pharmaceuticals, Inc. (CPIX) to Acquire Rights to Ifetroban from Vanderbilt

Today before the opening bell, Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, announced that it has signed an agreement to acquire the rights to ifetroban, a new Phase II development product. Cumberland acquired Ifetroban from Vanderbilt through its majority-owned subsidiary, Cumberland Emerging Technologies (CET). Under the brand name Hepatoren™ (ifetroban) Injection, the company has initiated clinical development and is evaluating the product for the treatment of critically ill hospitalized patients suffering from Hepatorenal Syndrome (HRS). Cumberland has already received clearance from the U.S. Food and Drug Administration (FDA) for its investigational new…

TuesdayApr 19, 2011 8:44 am

MedPro Safety Products (MPSP) and Greiner Bio-One GmbH Announce Product Launch of VACUETTE® Premium Safety Needle System Tube-Touch®

MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection, and its product partner Greiner Bio-One GmbH were excited to announce this morning the market release of the VACUETTE® PREMIUM Safety Needle System Tube-Touch. This patented technology enables the safety of a blood sample collection product with a truly passive needlestick prevention feature. Manufactured by Greiner Bio-One in their new state of the art facility in Upper Austria, the first production units are now available for purchase in the U.S. “The launch of the VACUETTE® PREMIUM Safety Needle System Tube-Touch product provides…

TuesdayApr 19, 2011 8:13 am

LookSmart Ltd. (LOOK) Appoints Scott Kauffman to Board of Directors

LookSmart, Ltd. announced the appointment of Scott Kauffman to its board of directors. Kauffman is also currently the Chairman of several internet-based venture-backed companies such as TuneUp Media, MetaChannels, Lotarme, and Minibox. Based in San Francisco, California, LookSmart is an online search advertising network solutions company for search advertisers and online publishers. LookSmart offers search advertising via its Advertiser Network and an Ad Center platform for online publishers. Kauffman is a business veteran of 25 years, with senior executive and board leadership experience in public and private companies, having spent a large amount of time in the internet media sector,…

TuesdayApr 19, 2011 8:11 am

BioSante Pharmaceuticals, Inc. (BPAX) Licenses Vaccine to Aduro BioTech

Yesterday, BioSante Pharmaceuticals, Inc. announced that it has licensed its Pancreas Cancer Vaccine and Prostate Cancer Vaccine to Aduro BioTech, a clinical-stage immunotherapy company, for use in combination with Aduro’s proprietary vaccine platform based on Listeria monocytogenes (Lm). BioSante will receive milestone and royalty payments after commercialization of combination cancer vaccines using BioSante’s cancer vaccine technology; Aduro also has an option to additional BioSante Cancer Vaccine indications, all for use in combination with its proprietary vaccine platform. CRS-207 is Aduro’s lead Lm-based therapeutic and has been engineered to express the tumor-associated antigen mesothelin. CRS-207 was evaluated in a Phase I…

MondayApr 18, 2011 5:10 pm

PharmStar Pharmaceuticals, Inc. (PHAR) Seeks New Facility to Expedite AQUAPRIN™ Marketing

The U.S. Food and Drug Administration (FDA) is a tough bird, no doubt about it. When it comes to meeting all of the rules and stringent guidelines, most investors only think about the safety and efficacy of a drug, but there is much more to it. Current Good Manufacturing Practices (CGMP) also play a large role in bringing a drug to market and, subsequently, keeping it on the market. PharmStar Phamaceuticals is on top of the guidelines and looking to possibly move into a new facility to accelerate the marketing of its main drug, AQUAPRIN™. AQUAPRIN™, an FDA-approved Over-the-Counter (OTC)…

MondayApr 18, 2011 5:03 pm

Jiangbo Pharmaceuticals, Inc (JGBO) Enters New Letter of Intent to Acquire Shandong Zinkangqi Medical Company

Jiangbo Pharmaceuticals Inc., a company that engages in the research, development, production, marketing, and sale of pharmaceutical products in China, has announced that Liayang Jiangbo Pharmaceutical Co., Ltd., a limited liability company that is organized in terms of the laws of PRC and is controlled by Jiangbo through contractual agreements, has signed a new Letter of Intent (LOI) with Shandong Xinkangqi Medical Company, a wholesale drug provider in the Shandong Province. The LOI entitles Laiyang Jiangbo to obtain 100% of the outstanding equity of Xinkangqi. Xinkangqi, which was founded in 2003, is one of the first companies in the Shandong…

Site Search

Company Search